Company
United StatesBret R. Rutherford, M.D., New York, NY – FDA Inspections
Inspection records and compliance data for Bret R. Rutherford, M.D. in New York, New York. 1 FDA inspection on record (1 OAI), 1 Form 483, 1 warning letter, last inspected January 10, 2023.
Company Profile
This profile covers Bret R. Rutherford, M.D. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 1
- VAI
- 0
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 1
Inspected January 10, 2023.
Most cited issue areas
- Changes in research1 inspection
- FD-1572, protocol compliance1 inspection
- General responsibilities of sponsors1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 10, 2023 | OAI | Human Drugs · Bioresearch Monitoring | 1194410 |
FDA documents
Form 483s (1)
Warning Letters (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bret R. Rutherford, M.D.
FEI Number
3023259471
Address
New York State Psychiatric Institute, 1051 Riverside Dr, New York, New York 10032, United States
Country
United States
ID: 6d3cd7ed-8400-4e3c-a7fe-f87d75722851